 Jennifer Hranilovich
Concepts (84)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Headache | 2 | 2024 | 147 | 1.600 |
Why?
| | Terminology as Topic | 1 | 2024 | 216 | 0.810 |
Why?
| | Transgender Persons | 2 | 2023 | 182 | 0.790 |
Why?
| | Headache Disorders, Primary | 1 | 2021 | 4 | 0.730 |
Why?
| | Headache Disorders, Secondary | 1 | 2021 | 4 | 0.730 |
Why?
| | Artificial Intelligence | 1 | 2024 | 275 | 0.710 |
Why?
| | Sexual and Gender Minorities | 2 | 2021 | 213 | 0.690 |
Why?
| | Biomedical Research | 2 | 2024 | 688 | 0.680 |
Why?
| | Hormone Replacement Therapy | 1 | 2021 | 96 | 0.670 |
Why?
| | White Matter | 2 | 2020 | 145 | 0.660 |
Why?
| | Drug Interactions | 1 | 2021 | 406 | 0.650 |
Why?
| | Evoked Potentials, Auditory, Brain Stem | 1 | 2020 | 50 | 0.630 |
Why?
| | Machine Learning | 1 | 2024 | 488 | 0.630 |
Why?
| | Brain Diseases | 1 | 2020 | 141 | 0.610 |
Why?
| | Cytomegalovirus Infections | 1 | 2020 | 191 | 0.580 |
Why?
| | Hearing Loss | 1 | 2020 | 220 | 0.520 |
Why?
| | Practice Guidelines as Topic | 2 | 2021 | 1569 | 0.510 |
Why?
| | Neurology | 3 | 2023 | 113 | 0.490 |
Why?
| | Headache Disorders | 2 | 2024 | 18 | 0.400 |
Why?
| | Brain | 2 | 2023 | 2664 | 0.390 |
Why?
| | Testosterone | 2 | 2023 | 401 | 0.230 |
Why?
| | Sertraline | 2 | 2013 | 29 | 0.200 |
Why?
| | Magnetic Resonance Imaging | 6 | 2023 | 3556 | 0.200 |
Why?
| | Brain Mapping | 2 | 2023 | 504 | 0.180 |
Why?
| | Migraine Disorders | 1 | 2021 | 101 | 0.170 |
Why?
| | Neuroimaging | 2 | 2020 | 259 | 0.160 |
Why?
| | Estrogens | 1 | 2023 | 368 | 0.160 |
Why?
| | Hearing Tests | 1 | 2020 | 47 | 0.160 |
Why?
| | Sex Distribution | 1 | 2020 | 374 | 0.160 |
Why?
| | Transition to Adult Care | 1 | 2020 | 81 | 0.150 |
Why?
| | Depressive Disorder, Major | 2 | 2013 | 362 | 0.150 |
Why?
| | Infant, Newborn, Diseases | 1 | 2020 | 113 | 0.150 |
Why?
| | Neonatal Screening | 1 | 2020 | 169 | 0.150 |
Why?
| | Research Personnel | 1 | 2020 | 171 | 0.150 |
Why?
| | Cerebral Cortex | 2 | 2012 | 433 | 0.140 |
Why?
| | Career Choice | 1 | 2020 | 216 | 0.140 |
Why?
| | Case-Control Studies | 2 | 2023 | 3540 | 0.130 |
Why?
| | Humans | 13 | 2024 | 136750 | 0.130 |
Why?
| | Prevalence | 1 | 2023 | 2708 | 0.120 |
Why?
| | Sex Characteristics | 2 | 2012 | 763 | 0.120 |
Why?
| | Longitudinal Studies | 1 | 2023 | 2829 | 0.120 |
Why?
| | Reproducibility of Results | 1 | 2023 | 3264 | 0.110 |
Why?
| | Antidepressive Agents | 2 | 2013 | 235 | 0.110 |
Why?
| | Retrospective Studies | 2 | 2023 | 15499 | 0.110 |
Why?
| | Mental Disorders | 1 | 2021 | 1070 | 0.100 |
Why?
| | Gyrus Cinguli | 1 | 2013 | 86 | 0.100 |
Why?
| | Puberty | 2 | 2012 | 146 | 0.100 |
Why?
| | Gray Matter | 1 | 2013 | 80 | 0.100 |
Why?
| | Prospective Studies | 2 | 2023 | 7572 | 0.100 |
Why?
| | Personality Inventory | 1 | 2012 | 140 | 0.100 |
Why?
| | Pediatrics | 1 | 2020 | 1094 | 0.100 |
Why?
| | Sexual Maturation | 1 | 2012 | 55 | 0.090 |
Why?
| | Temporal Lobe | 1 | 2012 | 91 | 0.090 |
Why?
| | Male | 8 | 2023 | 67305 | 0.080 |
Why?
| | Female | 7 | 2023 | 72785 | 0.080 |
Why?
| | Adolescent | 4 | 2023 | 21380 | 0.080 |
Why?
| | Child | 4 | 2023 | 21816 | 0.070 |
Why?
| | Infant, Newborn | 1 | 2020 | 6031 | 0.070 |
Why?
| | Infant | 1 | 2020 | 9395 | 0.060 |
Why?
| | Adult | 2 | 2023 | 37626 | 0.050 |
Why?
| | Social Stigma | 1 | 2021 | 134 | 0.040 |
Why?
| | Image Interpretation, Computer-Assisted | 2 | 2012 | 267 | 0.040 |
Why?
| | Neuropsychological Tests | 2 | 2013 | 1022 | 0.040 |
Why?
| | Consensus | 1 | 2020 | 678 | 0.030 |
Why?
| | Societies, Medical | 1 | 2020 | 816 | 0.030 |
Why?
| | Burnout, Professional | 1 | 2020 | 440 | 0.030 |
Why?
| | Parahippocampal Gyrus | 1 | 2012 | 9 | 0.030 |
Why?
| | Hypertrophy | 1 | 2013 | 133 | 0.020 |
Why?
| | Caudate Nucleus | 1 | 2012 | 23 | 0.020 |
Why?
| | Organ Size | 1 | 2012 | 477 | 0.020 |
Why?
| | Frontal Lobe | 1 | 2012 | 149 | 0.020 |
Why?
| | Age of Onset | 1 | 2013 | 518 | 0.020 |
Why?
| | Amygdala | 1 | 2012 | 191 | 0.020 |
Why?
| | Reaction Time | 1 | 2012 | 412 | 0.020 |
Why?
| | Neural Pathways | 1 | 2012 | 295 | 0.020 |
Why?
| | Cognition Disorders | 1 | 2012 | 495 | 0.020 |
Why?
| | Psychometrics | 1 | 2012 | 720 | 0.020 |
Why?
| | Treatment Outcome | 2 | 2013 | 10747 | 0.020 |
Why?
| | Hippocampus | 1 | 2012 | 894 | 0.020 |
Why?
| | Sex Factors | 1 | 2012 | 2064 | 0.020 |
Why?
| | Age Factors | 1 | 2012 | 3286 | 0.010 |
Why?
| | Young Adult | 1 | 2020 | 13126 | 0.010 |
Why?
| | Aged | 2 | 2013 | 23800 | 0.010 |
Why?
| | Middle Aged | 1 | 2012 | 33225 | 0.010 |
Why?
|
|
Hranilovich's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|